Russell Ford, Chairman & CEO, reported "revenue of $1.5 billion, growing 20% year-over-year and adjusted EBITDA of $196 million, up 16% year-over-year growth," citing demand strength across end ...
The company now expects net revenue of at least $775 million for full year 2025, up from previous guidance of at least $770 million. Adjusted EBITDA guidance was raised to at least $115 million from ...
Earnings Call Insights: Integra LifeSciences Holdings Corporation (IART) Q3 2025 The company revised its full year 2025 revenue and adjusted EPS guidance to $1.62 billion to $1.64 billion and $2.19 to ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果